Thursday, November 08, 2007

Ying Liu 1 , Ravi Retnakaran 1 , Anthony Hanley, Rungsunn ...
Journal of Clinical Endocrinology and Metabolism - Chevy Chase,MD,USA
Context/Objective: Decreased total adiponectin has been associated with metabolic disorders, including obesity, diabetes, fatty liver, and the metabolic ...
See all stories on this topic

Critical Knowledge About The Nervous System Uncovered By Rutgers Scientists
Uncover the neural communication links involved in myelination, the process of protecting a nerve's axon, and it may become possible to reverse the breakdown of the nervous system's electrical transmissions in such disorders as multiple sclerosis, spinal cord injuries, diabetes and cancers of the nervous system.07 Nov 2007

Rye Ridge Shopping Center gets face-lift
The Journal News / Lohud.com - Westchester,NY,USA
Acorda markets Zanaflex, a treatment for involuntary muscle movements caused by multiple sclerosis and spinal injuries. The company is conducting tests on ...
See all stories on this topic

Loss at biotech Acorda widens in third quarter

Acorda Therapeutics Inc., the biopharmaceutical company in Hawthorne, lost $8.5 million, or 30 cents a share, during the third quarter, compared with a loss of $7.2 million, or 37 cents a share, a year earlier, the company reported. Sales were up to $10.44 million from $6.16 million. Acorda markets Zanaflex, a treatment for involuntary muscle movements caused by multiple sclerosis and spinal injuries. The company is conducting tests on Famipridine-SR, a drug to help patients with MS walk more easily.

http://www.thejournalnews.com/apps/pbcs.dll/article?AID=/20071107/BUSINESS01/711070324/1066

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home